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A SERIES OF FOUR
CASE HISTORIES
PRESENTED FOR THE





These cases have been drawn from my clinical attachments
in the 4-th and 5th years of my medical studies. I have used
the case-reports to illustrate points of interest which are
discussed immediately after each report.
The first report was taken from my attachment at Bangour
General Hospital, the second and third from the Royal Infirmary
of Edinburgh and the last report is from the Royal Hospital for
Sick Children in Edinburgh.
Permission




Mr V.K. Age 59
Mr V.K. came to Scotland from Yugoslavia after World War
II. He worked as a manager for I.B.M. until ill health forced
his early retirement in 1984.. He lived in Linlithgow and was
happily married, with no children. His father died aged 43
and his mother aged 56, both from myocardial infarction. His
53 year old sister has arthritis and liver cirrhosis. He
smoked 4-0 cigarettes daily until the age of 55. He drank
alcohol only occasionally.
Mr V.K. was admitted to the medical wards at Bangour
General Hospital during my attachment there as a student in
June 1988. Previously he had cardiac catheterisation carried
out on him at Edinburgh Royal Infirmary and was too ill to go
home.
On the ward he complained of severe shortness of breath
on exertion, limiting his walking distance to a few yards. He
had no symptoms of angina pectoris. He had a cough productive
of yellow sputum. He had no haemoptysis or pleuritic chest
pain.
His past medical history was revealing. He had jaundice
as a child. He suffered sciatica aged 40. At the age of 48
he had a large anteroseptal myocardial infarction, from which
he recovered except for a few anginal symptoms. His choleste¬
rol and triglyceride levels were normal. 7 years later he had
increasing shortness of breath and two incidents of tight chest
pain. No acute changes were found to confirm a further
2
myocardial infarction, however JVP was markedly raised, gallop
rhythm and pulmonary and peripheral oedema were present. A
year later at the age of 55 Mr V.K. felt continually weak and
unable to work. A Chest X-Ray revealed gross cardiac enlarge¬
ment. A ventriculogram showed a dilated and globular left
ventricle with apical paradox suggesting the presence of a
ventricular aneurysm. Left ventricular ejection fraction was
15I at a heart rate of 90/minute. Mr V.K. was able to manage
reasonable at home until February 1988 when he was admitted to
Murrayfield Hospital, Edinburgh with jaundice. Liver function
tests showed mild hepatic dysfunction, bilirubin 37jamol/l.
Hepatic enlargement was found on ultrasound scan. It was
considered that this was secondary to cardiac failure since
liver biopsy failed to show any definite pathology. In April
1988 Mr V.K. was admitted to Bangour General Hospital with a
pulmonary embolus. He required large doses of diuretics to
control his pulmonary oedema. Another ventriculogram was
performed, showing a further reduction in left ventricular
ejection fraction to 8% at a heart rate of 100/minute. It was
considered that aneurysectomy would be impossible; cardiac
transplant would provide the best prognosis. In May 1988 Mr
V.K. had cardiac catheterisation performed, showing total
occlusion of the left anterior descending coronary artery.
The left ventricular wall was calcified and contracted poorly.
Mild pulmonary hypertension was present.
Mr V.K. was on the following medication: Bumetanide 5mg
b.d., KCL symp 10ml t.i.d., Captopril 12.5mg b.d., GTN p.r.n.,
lactulose 10ml nocte and Warfarin 2mg daily.
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On examination, Mr V.K. was jaundiced. His pulse was 80/
minute and blood pressure was low at 80/50mmHg. J.V.P. was
elevated at 15cm and was pulsatile. Gallop rhythm was present
but there were no murmurs. The apex beat was palpable in the
6th intercostal space, anterior axillary line, and was sus¬
tained throughout systole.
A rocking motion was palpable in systole, moving from
medial to lateral across the chest wall towards the apex beat.
Peripheral oedema was present to mid thigh level. Examination
of the chest revealed bilateral basal crepitations. The
abdomen exhibited shifting dullness to percussion and 5cm of
smooth hepatomegaly below the costal margin.
Chest X-Ray confirmed gross cardiomegaly and peripheral
oedema. An ECG showed freqent ventricular ectopics with Q
waves in chest leads - V^. A diagnosis of severe bi¬
ventricular failure secondary to ischaemic heart disease was
made.
During the week following admission, urea and electrolytes
were checked daily. Hyponatraemia on the 6th day (Sodium 131
mmol/1) necessitated cessation of diuretic therapy briefly.
Bilirubin was in the range 51 - 68pmol/l during this time.
Arrangements with Papworth Hospital in Cambridge were made in
preparation for cardiac transplantation.
On 23rd June 1988, eleven days after admission Mr V.K.
collapsed in the bathroom. He was cyanosed with fixed dilated
pupils. ECG confirmed asystole. Despite all efforts,
resuscitation proved unsuccessful. He was declared dead at
9.50a.m. Post mortem examination was not performed.
DISCUSSION
The use of clinical skills in the evaluation of cardiac
pathology is becoming less important in this age of high-
technology investigations. Yet in the Third World these
skills are vital and in Scotland the practitioner should use
them to determine which patients require urgent specialist
referral.
William Harvey (1628) used his acute but subjective senses
to find that "the heart erects itself and raises itself into a
point so that at this moment it strikes the chest wall, and
externally an impulse can be felt". In the early nineteenth
century Laennec and others held conflicting opinions as to the
timing of the apex beat in the cardiac cycle. Espinosa et al
(1983) review the early work of Chauveau and Marey from 1855 -
1861. They catheterised the right atrium and both ventricles
of anaesthetised horses to measure intracardiac pressure
changes and compared this with the onset and duration of the
apex beat. They concluded that the cardiac impulse represented
the forceful contraction of the heart muscle against the thorax
during ventricular systole.
The first authentic case of cardiac aneurysm was reported
by Hunter in 1757, although the clinical signs associated with
this condition were only elucidated in the early years of the
present century. Vakil (1955) looked at 20 cases of proven
ventricular aneurysm and found an anomalous location for the
cardiac impulse in 50$, a double impulse in 20$, a sustained
apex beat in 65$ and an undulating or wave-like impulse in
30$. A low pitched systolic murmur extending to early diastole
5
was also heard in 25% of cases.
In 1963, Deliyannis et al devised an instrument to measure
the apical impulse over time, a procedure called apex cardio¬
graphy. They found that in normal individuals the apical
impulse coincided with the first heart sound and had dis¬
appeared half way through ventricular systole. They noted
that a sustained impulse was characterised by prolongation of
the outward impulse up to or beyond the second heart sound.
They considered that the sustained impulse could be appreciated
on palpation and could be discribed as "heaving" in quality.
This sign was found in left ventricular hypertrophy and in
patients with ventricular aneurysm. Constrictive pericarditis
was associated with an impulse throughout diastole with in-
drawing of the chest in systole.
Brubakk et al (1982) examined fifteen patients with a
sustained apex beat using apex cardiography and other
investigations. They found this sign was associated with both
dilation and hypertrophy of the left ventricle with various
degrees of left ventricular failure clinically.
Other workers used the apex cardiogram to confirm the
work of Vakil, finding two chronological thrusts in the apex
beat in patients with cardiac aneurysm; traditionally a sign
associated with hypertrophic obstructive cardiomyopathy (Nagle
et al, 1966). This study on 800 patients by Ahuja and
Gutierrez in 1967 also noted a left ventricular rapid filling
wave in early diastole in patients with a low left ventricular
ejection fraction. They found this to be invariably accompa¬
nied by a loud third heart sound at the apex.
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Mr V.K., the subject of my case report had a sustained,
displaced apex beat with a rolling impulse medial to the
cardiac apex. A third heart sound was present and loud. The
literature review shows that the sustained apex beat may have
been due to his obvious ventricular dilation or caused by his
ventricular aneurysm. The rocking impulse medial to the apex
has only been described previously in cases of ventricular
aneurysm. Mr V.K. had no heart murmurs or double apical
impulse which may also be associated with cardiac aneurysm.
The third heart sound could be a product of early diastolic
ventricular filling as a consequence of very poor left ventri¬
cular ejection.
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CASE REPORT 2
Miss E.A. Age 84-
Miss E.A. is a spinster living alone in a ground floor
Edinburgh flat. She has a sister and niece who visit most
days. She herself seldom gets out of the house. A home help
comes three times a week. She visits the geriatric day
hospital twice weekly by ambulance and has recently had her
name added to the sheltered home list. She neither smokes
tobacco nor drinks alcohol.
On 4-th November 1 988 Miss E.A. was admitted to the medical
wards in the Royal Infirmary of Edinburgh where I was attached
as a student. She could not remember what had happened but
the police reported that she had fallen at home and although
she telephoned her G.P. she was unable to rise. She had
remained on the floor for an hour before the police broke in.
On systemic enquiry, Miss E.A. admitted to dizzyness on
looking upwards and occasional palpitations. Recently her
appetite had been poor.
Previous medical history included Temporal arteritis
2 years before. Vertigo and dysarthria following a left-
sided stroke 5 years previously. She had rheumatic fever as a
child. On admission her medication was Digoxin 0.0625mg t.d.s.
and Prednisolone 7mg daily.
On examination Miss E.A. was unable to walk but was not
distressed. She was dysarthric and dysphonic but with good
comprehension of speech. She was mildly tender over the
lumbar spine where she fell. Radial pulse was irregularly
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irregular, 64/minute. Apex beat was 110/minute, not displaced.
Blood pressure was 130/70mmHg. There was no cardiac murmur
and no other cardiovascular abnormalities were found, pulses
were all present and strong. Respiratory and Abdominal
systems were normal. On examination of the Central Nervous
System, cranial nerves were intact. Tone was increased
bilaterally and power reduced to 4/5 on the left side.
Reflexes were as shown below:
B Sup T K A PI
R: + + + + + + + + 9
L: + + + + + + + + +
Sensation was normal but finger-nose co-ordination was
poor. Urea and electrolytes were normal. Thyroid function
tests were normal. Liver function tests were mildly deranged;
Bilirubin 43pniol/l, ALT 36lu/l and C-GT 63Iu/l. Random blood
glucose was 8.8mmol/l. ECG confirmed atrial fibrillation and
showed ST depression and T elevation in the lateral chest
leads. At this point the differential diagnosis was Mild
stroke, Digoxin toxicity, Vasovagal attack and Myocardial
infarction. Prednisolone was increased to 7mg b.d. as the
ESR read at 40mm.
On 5th November biochemical tests were repeated. AST was
raised at 57Iu/l and urea -stable LDH elevated to 524Iu/l.
ECG had not changed from the previous day. The diagnosis now
was probable myocardial infarction. On bth November cardiac
enzymes continued.to rise.
On 7th November Miss E.A. became pyrexial and incontinent
of urine. MSU samples and blood culture failed to grow
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organisms. Chest X-Ray was normal, white cell count was 20.5 X
910 /l. She was slightly confused and paranoid. Augmentin
1.2g was commenced intravenously. AST and LDH had increased
to 106lu/l and 1677Iu/1 respectively.
On 8th November, Miss E.A. complained of tiredness. ECG
changes of ST depression were resolving. The digoxin level of
1.2nmol/l was thought to be adequate.
On 9th November Miss E.A. developed an intensely painful
left leg. Power was reduced to 4-/5 and light touch sensation
was lost,from the left foot. The left popliteal fossa was
tender and the left leg was colder and more mottled than the
right. Pulses were as shown below:
Fem Pop P.T. D.P.
7 R: ++ ++ ++ +
L: +
The impression was of an ischaemic left leg with arterial
occlusion secondary to cardiac mural thrombus from either
myocardial infarction or atrial fibrillation. A vascular
surgical opinion was gained and Miss E.A. was transferred to
their care for emergency embolectomy.
The surgeon reported that several large thrombi were
obtained from the superficial femoral artery, and subsequent
foot inspection showed good capillary perfusion and a pink
colouration. Cephuroxime 750mg was given pre and post¬
operatively. 3000 units of Heparin were given post-operatively.
Intramuscular Morphine 7.5mg p.r.n. was also prescribed.
On 10th November pulses in the left foot were strong, but
the right foot was becoming mottled in colour with absent
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pulses. Heparin was stopped and another emergency embolectomy
was performed in the same manner as before. On return from
theatre pulses in the right foot were strong. Thrombin time
ratio was 8:9 so heparin infusion was increased to 1000u/hour.
Miss E.A. was confused and aggressive that evening. Droperidol
5mg as well as oral augmentin was prescribed.
On 12th November thrombin time ratio was 19:9. Pulses
were all strong with legs exhibiting a good capillary return.
Haematological values were normal except for a low haemoglobin
of 10.9g/dl. She was transferred back to the medical wards
where it was found that the embolectomy scars were healing
well. Miss E.A. was still confused, dysarthric and in atrial
fibrillation. Haematological and biochemical indices were
largely unchanged.
On 15th November Warfarin was commenced. Prednisolone
was reduced to 1Omg daily with a view to reducing it to 7mg in
two days time. ECG showed ST depression had now totally
resolved with inverted T waves present in all chest levels.
On 17th November heparin was stopped. Miss E.A. continued to
mobilise.
On 23rd November the occupational therapists gave Miss
E.A. a departmental assessment. Although this and a home visit
went well it was considered that Part IV accommodation would
be most appropriate for her. Miss E.A. had refused to permit
changes to the house lay-out to make it safer. It was thought
that at the very least a community care alarm would need to be
provided if she was discharged home. Meanwhile she would
remain in hospital until problems of accommodation were
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resolved. On 16th December 1988 she was still waiting for
this .
DISCUSSION
This report on Miss E.A. illustrates a major problem in
the management of patients with atrial fibrillation. What is
the risk of systemic embolism in atrial fibrillation and under
what circumstances should prophylactic measures be taken to
discourage embolisation?
Hinton et al (1977) looked at 333 autopsy patients who
had atrial fibrillation associated with ischaemic heart
disease. He found that systemic emboli could be confirmed in
35% of these patients compared with 7% of a control group
without atrial fibrillation. Another study arguing that
atrial fibrillation is an independent risk factor for stroke
was carried out by Wolf et al in 1978 on the Framingham cohort.
He found that out of 5184 men and women followed over 24 years,
481 person-years of atrial fibrillation were:observed. He
looked at three groups; atrial fibrillation with rheumatic
heart disease, idiopathic atrial fibrillation and a control
group matched with subjects in the other groups for age, sex
and blood pressure. Stroke rate was 2.9/1000 person-years for
controls, 41-5/1000 person-years in idiopathic atrial fibril¬
lation and 45.5/1000 person-years in patients with atrial
fibrillation and rheumatic heart disease. The difference
between the two groups with atrial fibrillation was not
significant.
Other factors are important in the genesis of emboli in
atrial fibrillation. Petersen and Godtfredsen (1986) looked
at the rate of systemic embolism in 426 patients with
paroxysmal atrial fibrillation of whom 33.1$ developed chronic
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atrial fibrillation. It appeared that embolism was much
commoner at the onset of paroxysmal atrial fibrillation and
also in the first year of chronic atrial fibrillation. Caplan
et al (1986) thought that a large left atrium predisposed to
embolism in atrial fibrillation. He looked at previous echo¬
cardiograms of stroke patients and found that 90% had an
enlarged left atrium compared with 10% who had atrial fibril¬
lation without stroke. However Wiener (1987) discovered that
in idiopathic atrial fibrillation, neither the size of heart
chambers nor underlying heart disease made any difference to
rate of embolism.
When should measures be taken to prevent systemic
embolism? Some of the earliest work was performed by Cosgriff
in 1950. He put 18 patients in atrial fibrillation on
Dicumarol after embolism. He reported that 16 of these
patients had an uneventful course for 2 years after start of
therapy. Many more elegant studies were performed but even in
1986, Starkey and Warlow, reviewing the literature were unable
to be certain that a patient with stroke should receive anti¬
coagulants. They believed there had not been an adequate
randomised trial performed. The confusion amongst senior
physicians in the U.K. on this issue was highlighted by
Bucknell et al (1986) who sent questionnaires to 34-1 consul¬
tants. The proportion who would give anticoagulants in the
presence of atrial fibrillation ranged from 90% to 27% in
different types of mitral disease and to 19% in idiopathic
atrial fibrillation. The absence of any consistent policy on
therapy is obvious in the figures. Davidson's Principles and
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Practice of Medicine (1984.) emphasises the importance of
treating atrial fibrillation in mitral valve disease with
anticoagulants. However work by Roy et al (1986) suggests
that the incidence of systemic embolus is reduced by anti¬
coagulants irrespective of underlying pathology or whether
fibrillation is paroxysmal or chronic. Sherman et al (1986)
showed that the risk of embolus after stroke is about per
day in atrial fibrillation. Although anticoagulants reduce
this risk, the chance of extending a haemorrhagic cerebral
infarct is increased. Roy et al (1986) finds that serious
haemorrhagic complications occurred in 2.1/100 patient-years
in patients on anticoagulants in his study. Anticoagulants
reduced the risk of stroke from 5.5/100 patient-years to
0.7/100 patient-years. Conversion of atrial fibrillation to
sinus rhythm should be considered using antiarrhythmic agents
or D.C. shock. Digoxin may control the ventricular rate but
will not reduce the incidence of embolism. Mancini and
Goldberg (1982) report that cardioversion carries the risk of
embolism and that this procedure should be covered with anti¬
coagulation for two weeks before and after cardioversion.
Miss E.A., the subject of my case report, was in atrial
fibrillation treated with digoxin throughout her stay in
hospital. Anticoagulants were started after the first extra¬
cerebral embolism but not at a sufficient level to prevent a
second. Indeed thrombin time was below the therapeutic level
for two days after the second arterial embolism. Although
Miss E.A. had rheumatic fever as a child there were no signs
of rheumatic heart disease. Possibly her atrial fibrillation
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was of "idiopathic" type, the aetiology of which is most
probably ischaemic. Miss E.A. had suffered a stroke in the
past. It is possible that this was caused by embolism, but
this type tends to be a severe stroke with a high mortality.
Certainly this lady was fortunate that the emboli lodged in
accessible extracerebral arteries. Roy et al (1986) showed
that approximately 65l of emboli following atrial fibrillation
are in cerebral arteries. Perhaps this lady's mural infarct
provided the site for clot formation rather than the fibril-
lating left atrium. In any case she will need long-term
anticoagulation, given that we accept the risk of this therapy
in the absence of reliable research to prove its benefit.
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CASE REPORT 3
Mr A . T . Age 4.0
Mr A.T. is a charge nurse in an Edinburgh Hospital. He
recently moved from London with his boyfriend. He describes
this homosexual relationship as "solid". He smokes 10-15
cigarettes daily and drinks alcohol only occasionally.
He presented to his G.P. with shortness of breath on
exertion in October 1988. He was prescribed Erthromycin
which seemed to resolve the problem, however, he experienced
increasing shortness of breath again with exhaustion even on
climbing one flight of stairs. He developed a cough productive
of small amounts of white sputum. There was no history of
haemoptysis, wheeze or pleuritic pain. With this history he
was admitted to the Royal Infirmary on 21st November 1988,
six weeks after first consulting his G.P.
Mr A.T. admitted to promiscuous homosexual activities in
the early 1980's. In childhood he had an orchidopexy and
suffered from Perthes disease of the right hip. He had
hepatitis at the age of 30. Since 1986 Mr A.T. has had
generalised lymphadenopathy. Oral candidiasis with hairy
leukoplakia was diagnosed then at the Middlesex Hospital in
London, treated with Nystatin, Ketoconazole and Amphotericin
Lozenges. He was generally well until the onset of the present
complaint.
On examination Mr A.T. was seen to be communicative but
breathless. He was centrally cyanosed and pyrexial, tempera¬
ture 37.5°c. Oral candidiasis was present. His heart rate
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was 110/minute, blood pressure 130/80. He had a grade 2/6
ejection systolic murmur at the cardiac apex. The respiratory
system was normal on examination. His abdomen revealed 2cm
of smooth hepatomegaly below the costal margin.
A Chest X-Ray was performed which showed extensive
consolidation of the right and especially the left lower lobes.
Some prominence of both hilar regions was seen. The heart
size was normal. Blood tests suggested a low Haemoglobin of
12.6g/dl. Haematocrit of 37.2% was also low. The White cell
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count was not raised at 8.6 X 10/1. Blood chemistry was
normal. Arterial blood gas analysis revealed a low pO^ of
7.4kPa. Blood culture failed to grow organisms. Hepatitis B
surface antigen could not be detected.
On the afternoon of 21st November, emergency bronchoscopy
was arranged. There was no abnormal anatomy. Lavage was
performed with samples sent to laboratories. A few Proteus
colonies were grown which were sensitive to cotrimoxazole.
Pathology reported several aggregates of Pneumocystitis carinii
encysted trophozoites lying in a proteinaceous exudate.
Mr A.T. was counselled about consenting to the test for
H.I.V. positivity. He agreed, although on previous occasions
had refused to give permission. The result indicated that he
had H.I.V. infection. Immune cell monitoring showed severe
reduction in CD^cells with many activated CDg cells, consistent
with advanced H.I.V. infection. Monoclonal antibodies to
Pneumocystis carinii were isolated by the virology laboratory.
A diagnosis of Acquired Immune Deficiency Syndrome was
made,. complicated by Pneumocystis carinii infection.
Therapeutic measures were instigated: High dose intravenous
Cotrimoxazole 2.0g q.i.d., Metoclopramide 1Omg t.i.d. orally,
Prednisolone 60mg daily and 35% Oxygen were prescribed.
On 22nd November Mr A.T. was more comfortable. He was
no longer pyrexial. Fluconazole 50mg daily was prescribed for
the oral candidiasis. He complained of reduced hearing on
the left. On examination a small red papular lesion was seen
in the external auditory meatus. A Kaposi's sarcoma was
considered, but an E.N.T. opinion revealed no loss of hearing
and no sinister pathology.
On 23rd November the chest was clear on examination.
However Chest X-Ray showed no change in the widespread inter¬
stitial shadowing. pO^ and pCo^ were low at 8.6 and 4-• 2 kPa
respectively. The Clinical Psychologist assessed Mr A.T. and
found him to be dismayed at the diagnosis of A.I.D.S. but
that it was not totally unexpected to him. He agreed to talk
to a previously diagnosed H.I.V. infected volunteer with a
view to receiving help from the Edinburgh "buddy" scheme.
On 24-th November haematological tests showed that haemo¬
globin had fallen to 10.7g/dl. White cell and platelet counts
were normal. The cytopaenic effects of cotrimoxazole were
perhaps being seen in the low haemoglobin level. pO^ had
fallen again to 7.7 kPa.
From 26th to 28th November Mr A.T. was feeling less
breathlesss but still without resolution of shadows on X-Ray.
pO^ rose to 8.4- kPa, haemoglobin level was 11.5g/dl.
On 29th November Prednisolone was gradually reduced.
Cotrimoxazole was continued. Mr A.T. improved clinically and
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was discharged on 2nd December 1988 on Azidothymidine (AZT)
300mg q.i.d. Review was arranged for one week.
DISCUSSION
The emergence of Pneumocystis carinii as a clinically
important pathogen and its association with the Acquired
Immune Deficiency syndrome has been well documented since 1981.
In June of that year the Centre of Disease Control in the
United States reported five cases of Pneumocystis carinii
pneumonia in homosexual men in the Los Angeles area; the first
indication that AIDS was a clinical problem. Previously the
protozoa had been described as causing pneumonia largely in
malnourished children in Eastern Europe and Iran.
The case report on Mr A.T. illustrates some of the
problems in management of Pneumocystis carinii pneumonia.
Firstly there is difficulty in diagnosis. Mr A.T.
presented with the typical triad of fever, dyspnoea and hypoxia.
Cough is only an occasional feature. X-Ray changes of wide¬
spread interstitial shadowing may, together with few clinical
signs mimic an acute alveolitis. The history of drug abuse or
homosexual activity will however raise the possibility of
Pneumocystis infection (Stark et al, 1986), but this is not
always volunteered.
Problems exist in investigating the illness. Until two
years ago, a serological test did not exist for the protozoa.
Very seldom do the organisms appear in sputum and lavage will
not reveal cysts unless special stains are used, such as
methenamine silver (Robbins et al 1 984.) •
Treatment involves the use of antifolate agents to
inhibit the dihydrofolate reductaze enzyme in P. carinii. Two
agents are currently used; Trimethoprim-sulfamethoxazole
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(co-trimoxazole) and Pentamidine isethionate. Sattler et al
(1988) compared the two agents. 36 patients randomly received
co-trimoxazole, 90 - 120mg/kg/day. They found that co-
trimoxazole produced rashes in -44-$ and anaemia in 39$. with
86$ survival at 2 year follow-up. Pentamidine caused nephro¬
toxicity in 64$, hypotension in 27$ and hypoglycaemia in 2-4$,
with 61$ survival at 2 year follow-up. The British National
Formulary suggests co-trimoxazole as first-line therapy,
despite its side-effects, some of which appear to be worse in
patients with AIDS. For example tremor has been reported in -4
cases from one centre in Texas sufficient to stop treatment
(Borucki et al, 1988). Pentamidine is recommended only when
co-trimoxazole has failed to clear the pneumonia and even then
only in specialist centres. Nephrotoxicity elevates creatinine
levels and occurs commonly. The dose then needs to be
adjusted.
If treatment is delayed mortality is high. Superinfection
with bacteria, fungi and viruses, especially Cytomegalovirus
occurs. Clinical resolution of the pneumonia may only be
partial, as reported by el Sadr in 1986; although clinically
responsive to co-trimoxazole, trophozoites continued to be
present in alveoli of one patient reported.
New drugs are appearing now. Kovacs (1988) showed that
Piritrexim would inhibit P. Carinii dihydrofolate reductase
at one thousandth the concentration of traditional antifolate
drugs^in vitro. el Sadr (1986) recommends that drugs capable
of destroying trophozoites must be developed if P. carinii is
truly to be eradicated in AIDS sufferers.
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Mr A.T.'s chest radiograph continued to show signs of
infection even at discharge from hospital. In patients like
him other drugs to co-trimoxazole may well be necessary,
employed in specialist centres to improve the prognosis in
this tragic syndrome.
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Miss M.K. Age 14-
Miss M.K. is a Chinese girl attending Boroughmuir School
in Edinburgh. She was born in Preston to immigrant parents
from Hong Kong. At the age of 1 they moved to Edinburgh where
her father works as a chef. She has two sisters aged 19 and
21 and the family live in a small flat on the Royal Mile.
I first met Miss M.K. in the Outpatient department at the
Royal Hospital for Sick Children in February 1988. The
registrar specialising in diabetes found blood glucose level
to be 14-mmol/l and expressed surprise that Glycosylated
Haemoglobin was 17.6$. He explained that Miss M.K. was both
diabetic and thalassaemic but with home circumstances
suggesting good motivation for diabetic control.
I thought about the problem, and wondered if the haemo-
globinopathy could interfere with measurement of Haemoglobin
A,j . I determined to find out about this and more about the
patient's medical problems.
At the age of 1, Miss M.K. was diagnosed as having p
thalassaemia major during an admission for failure-to-thrive
at Edinburgh Royal Hospital for Sick Children. Her sisters
and both parents were found to have p thalassaemia minor.
Many distant family members in Hong Kong were also known to
have thalassaemia. In May 1986 she was admitted with diabetic
ketoacidosis and was found to be prepubertal at age 13.
Further investigation revealed hypothyroidism. The diabetes
mellitus and pan hypopituitarism were considered to be the
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result of haemosiderosis, consequent of frequent transfusions
for her haemolytic anaemia. Therapeutic measures initiated at
this point included Ethinyloestradiol 4-ug/day, Thyroxine
150]ig/day, Desferrioxamine 2.5g subcutaneously by infusion
pump overnight, Insulin given as 30 units Velosulin plus 36
units Insulatard before breakfast and 30 units Velosulin plus
30 units Insulatard before supper.
Haemoglobin concentration was measured fortnightly, and
hospital admissions arranged six weekly for infusion of 4-
units washed red cells. This tended to raise the haemoglobin
from around 9g/dl to 15 or I6g/dl.
When I met Miss M.K. she appeared obese with a height of
1.4-Om; below the third percentile for her age. Her skin seemed
to have a bronze tinge with several fading bruises. She had no
pubic hair and only slight breast development. There were no
other abnormalities on examination except for a smooth liver
edge 1cm below the costal margin. There was no palpable
splenomegaly. Investigations showed normal urea and electro¬
lyte levels. Serum ferritin was grossly raised at 4-1 ^Jig/ml.
Serum iron was moderately raised at 65pimol/l.
Miss M.K. began to experience hypoglycaemic attacks in
June 1987. In September of that year her notes included the
comment that Glycosylated haemoglobin was consistently and
unacceptably high, especially since haemolytic anaemia is
usually associated with a low Haemoglobin due to a high red
cell turnover. As a result her evening insulin was increased
to 32 units Velosulin plus 32 units Insulatard. She continued
to experience hypoglycaemic episodes.
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Miss M.K. is a well motivated patient with a supportive
family. Her good command of English helps in education about
her medical problems but the future surely holds many diffi¬
culties for this girl. Medical problems must be treated
aggressively and lifestyle will thus be radically affected if
she is not to have a very guarded prognosis.
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DISCUSSION
Shortly after seeing Miss M.K. in the Diabetic Out-
Patient clinic I reviewed the literature to discover any
record of abnormal haemoglobin molecules interfering with
measurements of glycosylated haemoglobin levels. I found a
number of relevant references.
The routine methods for measuring glycosylated haemo¬
globin (Haemoglobin ) in diabetes are agar gel electro¬
phoresis and column chromatography. These depend on
glycosylated haemoglobin having a different electrical charge
to adult haemoglobin. The tests do not distinguish between
glycosylated haemoglobin and foetal haemoglobin which both
migrate together (Paisley et al 1984- a).
Hall et al (1983) showed that the use of simple affinity
chromatography to measure haemoglobin gave a falsely high
value if foetal haemoglobin was present in the blood. Paisley
et al (1 984. a) reported two cases of insulin-dependent diabetic
women with persistently high glycosylated haemoglobin levels
as measured by agar gel electrophoresis. This was associated
with only moderately raised blood glucose; an unexpected
finding. Both patients had recently been prescribed greater
amounts of insulin on the basis of haemoglobin A^ levels, and
both experienced frequent hypoglycaemic episodes as a result.
Foetal haemoglobin was measured and was found to be present in
their blood at 2.6% and 5.0% (normal levels <0.7%). When
Haemoglobin A^ was measured in these patients using a thio-
barbituric acid reaction, a lower value was found; more
consistent with the blood glucose readings. These workers
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recommended that agar gel electrophoresis should not be used
in pregnant diabetic women or in haemoglobinopathies, which
may be associated with high levels of foetal haemoglobin.
Saitta et al (1 984-) studied 32 non-diabetic mothers of babies
with thalassaemia and found that glycosylated haemoglobin
levels using a chromatographic method were higher than in
controls (9.3$ compared with 7.1$). This difference was
especially marked in mothers who had detectable levels of
foetal haemoglobin.
These studies illustrate the problem of using electro-
phoretic or chromatographic methods in the measurement of
glycosylated haemoglobin when foetal haemoglobin is also
present in the blood. Paisley et al (1984- a) suggest that a
thiobarbituric acid reaction would give more accurate results.
In a separate report they find glycosylation of human hair
also to be a useful indicator of diabetic control (Paisley et
al, 1 984- b) . Hall et al (1983) suggest that measurement of
glycosylated plasma proteins might be valuable too in deter¬
mining medium-term diabetic control in the presence of foetal
haemoglobin.
thalassaemia is a haemoglobinopathy characterised by
lack of )5 globulin chain synthesis of adult haemoglobin.
Foetal haemoglobin consisting of two alpha chains and two
gamma chains (^2 ^2^ is Presen"k» together with haemoglobin A£
(°<2 <5 2) and sometimes normal adult haemoglobin Miss
M.K. did not have foetal haemoglobin measured, but after
attention was drawn to the above studies, glycosylated
haemoglobin levels were no lohger used to determine her
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diabetic control. Her evening insulin requirements were also
reduced from 32 to 30 units of Velosulin and Insulatard.
An additional problem of thalassaemic patients is
reported by Kattamis et al (1987). They found a marked
increase in renal glucose threshold in these patients compared
to controls. Thus in thalassaemia, glycosuria may also be
misleading in the assessment of diabetic control.
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